Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma

American Journal of Pathology

Volumn 180, Issue 5, 2012, Pages 1798-1807

  Che, Yufang ^a   Ye, Fei ^b   Xu, Ruliang ^c   Qing, Haitao ^a   Wang, Xinying ^a   Yin, Fei ^b   Cui, Miao ^a   Burstein, David ^b   Jiang, Bo ^a   Zhang, David Y ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; EMBELIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NOTCH4 RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN C JUN; PROTEIN CDC42; PROTEIN P27; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR TWIST; VASCULOTROPIN RECEPTOR; X LINKED INHIBITOR OF APOPTOSIS; BENZOQUINONE DERIVATIVE; CCND1 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN; XIAP PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CORRELATION ANALYSIS; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOLECULARLY TARGETED THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; AGED; CANCER STAGING; CELL CYCLE; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; TUMOR CELL CULTURE;

AGED; APOPTOSIS; BENZOQUINONES; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL PROLIFERATION; CYCLIN D1; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PHOSPHORYLATION; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84860254385     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.01.016     Document Type: Article

References (26)

1. M.A. Avila, C. Berasain, B. Sangro, J. Prieto New therapies for hepatocellular carcinoma Oncogene 25 2006 3866 3884
2. F.X. Bosch, J. Ribes, M. Diaz, R. Cleries Primary liver cancer: worldwide incidence and trends Gastroenterology 127 2004 S5 S16
3. C.D. Mann, C.P. Neal, G. Garcea, M.M. Manson, A.R. Dennison, D.P. Berry Prognostic molecular markers in hepatocellular carcinoma: a systematic review Eur J Cancer 43 2007 979 992
4. J.T. Feng, S. Shang, L. Beretta Proteomics for the early detection and treatment of hepatocellular carcinoma Oncogene 25 2006 3810 3817
5. R.W. Pang, R.T. Poon From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now Oncology 72 Suppl 1 2007 30 44
6. A. Villanueva, P. Newell, D.Y. Chiang, S.L. Friedman, J.M. Llovet Genomics and signaling pathways in hepatocellular carcinoma Semin Liver Dis 27 2007 55 76
7. K.K. Li, I.O. Ng, S.T. Fan, J.H. Albrecht, K. Yamashita, R.Y. Poon Activation of cyclin-dependent kinases CDC2 and CDK2 in hepatocellular carcinoma Liver 22 2002 259 268
8. Y.H. Shi, W.X. Ding, J. Zhou, J.Y. He, Y. Xu, A.A. Gambotto, H. Rabinowich, J. Fan, X.M. Yin Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence Hepatology 48 2008 497 507
9. F. Ye, Y. Che, E. McMillen, J. Gorski, D. Brodman, D. Saw, B. Jiang, D.Y. Zhang The effect of Scutellaria baicalensis on the signaling network in hepatocellular carcinoma cells Nutr Cancer 61 2009 530 537
10. H. Wang, A. Gillis, C. Zhao, E. Lee, J. Wu, F. Zhang, F. Ye, D.Y. Zhang Crocidolite asbestos-induced signal pathway dysregulation in mesothelial cells Mutat Res 723 2011 171 176
11. J. Wang, X. Wang, W. Gong, B. Mi, S. Liu, B. Jiang Increased expression of beta-catenin, phosphorylated glycogen synthase kinase 3beta, cyclin D1, and c-myc in laterally spreading colorectal tumors J Histochem Cytochem 57 2009 363 371
12. R.T. Lima, L.M. Martins, J.E. Guimaraes, C. Sambade, M.H. Vasconcelos Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells Cancer Gene Ther 11 2004 309 316
13. E.J. Cram, B.D. Liu, L.F. Bjeldanes, G.L. Firestone Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter J Biol Chem 276 2001 22332 22340
14. T. Hasegawa, K. Suzuki, C. Sakamoto, K. Ohta, S. Nishiki, M. Hino, N. Tatsumi, S. Kitagawa Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia Blood 101 2003 1164 1171
15. D.Y. Zhang, F. Ye, L. Gao, X. Liu, X. Zhao, Y. Che, H. Wang, L. Wang, J. Wu, D. Song, W. Liu, H. Xu, B. Jiang, W. Zhang, J. Wang, P. Lee Proteomics, pathway array and signaling network-based medicine in cancer Cell Div 4 2009 20
16. X. Zhang, N. Dong, L. Yin, N. Cai, H. Ma, J. You, H. Zhang, H. Wang, R. He, L. Ye Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues J Med Virol 77 2005 374 381
17. R. Sakemi, H. Yano, S. Ogasawara, J. Akiba, O. Nakashima, S. Fukahori, M. Sata, M. Kojiro X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues Oncol Rep 18 2007 65 70
18. E.A. Sausville Complexities in the development of cyclin-dependent kinase inhibitor drugs Trends Mol Med 8 2002 S32 S37
19. C.J. Sherr G1 phase progression: cycling on cue Cell 79 1994 551 555
20. Z. Nikolovska-Coleska, L. Xu, Z. Hu, Y. Tomita, P. Li, P.P. Roller, R. Wang, X. Fang, R. Guo, M. Zhang, M.E. Lippman, D. Yang, S. Wang Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database J Med Chem 47 2004 2430 2440
21. P.J. Jost, S. Grabow, D. Gray, M.D. McKenzie, U. Nachbur, D.C. Huang, P. Bouillet, H.E. Thomas, C. Borner, J. Silke, A. Strasser, T. Kaufmann XIAP discriminates between type I and type II FAS-induced apoptosis Nature 460 2009 1035 1039
22. M. Gyrd-Hansen, P. Meier IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer Nat Rev Cancer 10 2010 561 574
23. H. Yang, N. Magilnick, X. Ou, S.C. Lu Tumour necrosis factor alpha induces co-ordinated activation of rat GSH synthetic enzymes via nuclear factor kappaB and activator protein-1 Biochem J 391 2005 399 408
24. D. Joyce, C. Albanese, J. Steer, M. Fu, B. Bouzahzah, R.G. Pestell NF-kappaB and cell-cycle regulation: the cyclin coion Cytokine Growth Factor Rev 12 2001 73 90
25. L. Bakiri, D. Lallemand, E. Bossy-Wetzel, M. Yaniv Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression EMBO J 19 2000 2056 2068
26. C. Van Themsche, V. Leblanc, S. Parent, E. Asselin X-linked inhibitor of apoptosis protein (XIAP) regulates PTEN ubiquitination, content, and compartmentalization J Biol Chem 284 2009 20462 20466